Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple-Negative Invasive Breast Carcinoma|Residual Tumor
Interventions: DRUG: Carmustine|DRUG: Cyclophosphamide|DRUG: Carboplatin|PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation|DRUG: Busulfan
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran